Preclinical News and Research

RSS
International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

New CRUK-MEDI Alliance Laboratory to focus on development of novel biologic cancer treatments

New CRUK-MEDI Alliance Laboratory to focus on development of novel biologic cancer treatments

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

XenOPAT aims to advance development of new drugs against cancer, personalized cancer treatments

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

NIH awards $10.1 million in supplemental funding to study effects of sex in preclinical, clinical studies

NIH awards $10.1 million in supplemental funding to study effects of sex in preclinical, clinical studies

Blocking AEG-1 gene expression halts development of liver cancer by regulating inflammation

Blocking AEG-1 gene expression halts development of liver cancer by regulating inflammation

Oxabact now recognized as potential treatment for Short Bowel Syndrome

Oxabact now recognized as potential treatment for Short Bowel Syndrome

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Avalon Ventures, GSK jointly launch two new early-stage life science companies

Propanc, Southridge Partners enter into equity purchase agreement

Propanc, Southridge Partners enter into equity purchase agreement

Photoacoustics could become alternative to mammography or sonogram for breast cancer detection

Photoacoustics could become alternative to mammography or sonogram for breast cancer detection

Researchers develop protein therapy that may stop cancer growth

Researchers develop protein therapy that may stop cancer growth

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

New approach to imaging metastatic tumors

New approach to imaging metastatic tumors

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

Six research institutions awarded NIH grants to create database of human cellular responses

Six research institutions awarded NIH grants to create database of human cellular responses

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix acquires novel orphan drug candidate for treatment of CTCL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.